MAX Chat
China Shineway Pharmaceutical Group Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
8.21 | -27.77 | -129.58% | 9.26 | -11.31% |
| P/S |
|
1.83 | 54.94 | -96.68% |
|
|
| P/BV |
|
0.9242 | 3.06 | -69.84% |
|
|
| P/FCF |
|
7.66 | 15.9 | -51.79% |
|
|
| Ev/Ebitda |
|
0.6 | 28.92 | -97.93% |
|
|
| Ev/S |
|
0.1758 | -0.5462 | -132.19% |
|
|
| Ev/FCF |
|
0.807 | -7.03 | -111.47% |
|
|
| E/P |
|
0.1332 | 0.0191 | 598.9% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
8/10
|
29.21 | -262.41 | -111.13% | 26.43 | +10.53% |
| ROE |
|
11.59 | -5.11 | -326.91% |
|
|
| ROA |
|
8.57 | 0.2788 | 2972.15% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
22.24 | -266.12 | -108.36% |
|
|
| ROCE |
|
0 | 0.6626 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0067 | 0.5873 | -98.86% | 0.1232 | -94.56% |
| Nеt Debt/Ebitda |
|
0 | -1.27 | -100% |
|
|
| Debt/Ratio |
|
0.000737 | 0.1352 | -99.45% |
|
|
| Debt/Equity |
|
0.3448 | 0.8667 | -60.22% |
|
|
| Debt/Net Income |
|
0.0088 | 2.28 | -99.61% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
10/10
|
7.46 | 2.97 | 151.14% | 9.63 | -22.55% |
| Number of years of dividend growth |
|
2 | 1.26 | 58.62% | ||
| DSI |
|
0.7857 | 0.5452 | 44.1% |
|
|
| Average dividend growth |
|
11.45 | 8.21 | 39.41% |
|
|
| Average percentage for 5 years |
|
9.63 | 3.04 | 216.7% |
|
|
| Average percentage for payments |
|
46.24 | 34.24 | 35.02% |
|
|
| Difference from average difference in sector |
|
4.49 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
5/10
|
30.66 | 14.18 | 116.22% | ||
| Growth impulse Ebitda in 5 years |
|
44.48 | 64.12 | -30.63% | ||
| Growth impulse Net Income in 5 years |
|
161.87 | 22.8 | 609.96% | ||
| Growth impulse FCF in 5 years |
|
32.2 | 146.59 | -78.03% | ||
| Growth impulse EPS in 5 years |
|
185.87 | -78.65 | -336.33% |
IP Score
7.72/10
